February 02, 2023
2 min watch
Save
VIDEO: Study identifies early treatment patterns, responses for faricimab in wet AMD, DME
Issue: March 10, 2023
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
KOLOA, Hawaii — In this Healio Video Perspective from Retina 2023, Ferhina S. Ali, MD, MPH, discusses the early use of faricimab for the treatment of neovascular age-related macular degeneration and diabetic macular edema.
“In terms of vision response, we saw that, for those who were treatment naive, they had steady improvement in their vision over the course of their injections,” she said. “For those who had been prior treated with good vision, they maintained stable vision over the course of their treatments.”
Published by:
Sources/Disclosures
Collapse
Source:
Ali FS. Real world use of faricimab from the IRIS Registry. Presented at: Retina 2023; Jan. 14-20, 2023; Koloa, Hawaii.
Disclosures:
Ali reports no relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.